Crossref journal-article
Rockefeller University Press
The Journal of Experimental Medicine (291)
Abstract

Systemic autoimmune disease in humans and mice is characterized by loss of immunologic tolerance to a restricted set of self-nuclear antigens. Autoantigens, such as double-stranded (ds) DNA and the RNA-containing Smith antigen (Sm), may be selectively targeted in systemic lupus erythematosus because of their ability to activate a putative common receptor. Toll-like receptor 9 (TLR9), a receptor for CpG DNA, has been implicated in the activation of autoreactive B cells in vitro, but its role in promoting autoantibody production and disease in vivo has not been determined. We show that in TLR9-deficient lupus-prone mice, the generation of anti-dsDNA and antichromatin autoantibodies is specifically inhibited. Other autoantibodies, such as anti-Sm, are maintained and even increased in TLR9-deficient mice. In contrast, ablation of TLR3, a receptor for dsRNA, did not inhibit the formation of autoantibodies to either RNA- or DNA-containing antigens. Surprisingly, we found that despite the lack of anti-dsDNA autoantibodies in TLR9-deficient mice, there was no effect on the development of clinical autoimmune disease or nephritis. These results demonstrate a specific requirement for TLR9 in autoantibody formation in vivo and indicate a critical role for innate immune activation in autoimmunity.

Bibliography

Christensen, S. R., Kashgarian, M., Alexopoulou, L., Flavell, R. A., Akira, S., & Shlomchik, M. J. (2005). Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus. The Journal of Experimental Medicine, 202(2), 321–331.

Authors 6
  1. Sean R. Christensen (first)
  2. Michael Kashgarian (additional)
  3. Lena Alexopoulou (additional)
  4. Richard A. Flavell (additional)
  5. Shizuo Akira (additional)
  6. Mark J. Shlomchik (additional)
References 68 Referenced 436
  1. 10.7326/0003-4819-83-4-464 / Ann. Intern. Med. (1975)
  2. 10.1016/S0092-8674(00)81108-3 / Cell. (1996)
  3. 10.1038/nri976 / Nat. Rev. Immunol. (2003)
  4. 10.1016/S0889-857X(21)00735-3 / Rheum. Dis. Clin. North Am. (1992)
  5. 10.1056/NEJM199805073381906 / N. Engl. J. Med. (1998)
  6. 10.1136/jcp.53.6.424 / J. Clin. Pathol. (2000)
  7. 10.1146/annurev.immunol.21.120601.141126 / Annu. Rev. Immunol. (2003)
  8. 10.1038/ni1112 / Nat. Immunol. (2004)
  9. 10.1038/35047123 / Nature. (2000)
  10. 10.1182/blood-2002-11-3569 / Blood. (2003)
  11. 10.1038/416603a / Nature. (2002)
  12. 10.1016/S1074-7613(03)00323-6 / Immunity. (2003)
  13. 10.1177/09680519040100040801 / J. Endotoxin Res. (2004)
  14. 10.1038/35099560 / Nature. (2001)
  15. 10.1074/jbc.M310175200 / J. Biol. Chem. (2004)
  16. 10.1016/S0955-0674(00)00211-8 / Curr. Opin. Cell Biol. (2001)
  17. 10.1146/annurev.iy.09.040191.001331 / Annu. Rev. Immunol. (1991)
  18. 10.4049/jimmunol.133.1.227 / J. Immunol. (1984)
  19. 10.1084/jem.180.4.1295 / J. Exp. Med. (1994)
  20. 10.4049/jimmunol.157.1.417 / J. Immunol. (1996)
  21. 10.1002/art.1780251101 / Arthritis Rheum. (1982)
  22. 10.1002/art.1780400910 / Arthritis Rheum. (1997)
  23. {'key': '2023072513185829200_BIB23'}
  24. 10.1111/j.1749-6632.1975.tb29197.x / Ann. NY Acad. Sci. (1975)
  25. 10.1136/ard.46.6.448 / Ann. Rheum. Dis. (1987)
  26. 10.5858/2000-124-0071-GFCUOT / Arch. Pathol. Lab. Med. (2000)
  27. 10.1016/S0021-9258(18)91101-4 / J. Biol. Chem. (1984)
  28. 10.4049/jimmunol.150.4.1591 / J. Immunol. (1993)
  29. 10.1073/pnas.241510698 / Proc. Natl. Acad. Sci. USA. (2001)
  30. 10.1056/NEJMoa021933 / N. Engl. J. Med. (2003)
  31. 10.1016/S0896-8411(02)00114-2 / J. Autoimmun. (2003)
  32. 10.1038/35100573 / Nat. Rev. Immunol. (2001)
  33. 10.1073/pnas.0337679100 / Proc. Natl. Acad. Sci. USA. (2003)
  34. 10.1084/jem.20021553 / J. Exp. Med. (2003)
  35. 10.4049/jimmunol.173.8.5283 / J. Immunol. (2004)
  36. 10.1084/jem.20021996 / J. Exp. Med. (2003)
  37. 10.4049/jimmunol.173.3.2134 / J. Immunol. (2004)
  38. 10.1084/jem.20030162 / J. Exp. Med. (2003)
  39. 10.1126/science.1087262 / Science. (2003)
  40. 10.1093/intimm/11.10.1693 / Int. Immunol. (1999)
  41. 10.1093/intimm/dxg020 / Int. Immunol. (2003)
  42. 10.4049/jimmunol.167.5.2602 / J. Immunol. (2001)
  43. 10.1084/jem.20031942 / J. Exp. Med. (2004)
  44. 10.1038/ni1028 / Nat. Immunol. (2004)
  45. 10.1084/jem.179.4.1317 / J. Exp. Med. (1994)
  46. 10.1101/gad.1022802 / Genes Dev. (2002)
  47. 10.1038/ni1146 / Nat. Immunol. (2005)
  48. 10.1084/jem.20012094 / J. Exp. Med. (2002)
  49. 10.1146/annurev.immunol.22.012703.104549 / Annu. Rev. Immunol. (2004)
  50. 10.1093/intimm/dxf046 / Int. Immunol. (2002)
  51. 10.4049/jimmunol.164.11.5998 / J. Immunol. (2000)
  52. 10.4049/jimmunol.168.9.4531 / J. Immunol. (2002)
  53. 10.1126/science.1093616 / Science. (2004)
  54. 10.1126/science.1093620 / Science. (2004)
  55. 10.1038/nature01783 / Nature. (2003)
  56. 10.1038/ni1010 / Nat. Immunol. (2003)
  57. 10.1038/nature03124 / Nature. (2004)
  58. 10.1084/jem.20030130 / J. Exp. Med. (2003)
  59. 10.1002/art.1780371118 / Arthritis Rheum. (1994)
  60. 10.1038/ki.1992.242 / Kidney Int. (1992)
  61. 10.1136/ard.62.6.556 / Ann. Rheum. Dis. (2003)
  62. 10.1084/jem.20031519 / J. Exp. Med. (2004)
  63. 10.1084/jem.189.10.1639 / J. Exp. Med. (1999)
  64. 10.1016/S1074-7613(01)00251-5 / Immunity. (2001)
  65. 10.1016/j.cell.2004.07.002 / Cell. (2004)
  66. 10.1073/pnas.97.3.1184 / Proc. Natl. Acad. Sci. USA. (2000)
  67. 10.1002/eji.1830131107 / Eur. J. Immunol. (1983)
  68. 10.1126/science.7025211 / Science. (1981)
Dates
Type When
Created 20 years, 1 month ago (July 18, 2005, 3:03 p.m.)
Deposited 2 years, 1 month ago (July 25, 2023, 9:21 a.m.)
Indexed 3 days, 1 hour ago (Sept. 3, 2025, 6:15 a.m.)
Issued 20 years, 1 month ago (July 18, 2005)
Published 20 years, 1 month ago (July 18, 2005)
Published Online 20 years, 1 month ago (July 18, 2005)
Published Print 20 years, 1 month ago (July 18, 2005)
Funders 0

None

@article{Christensen_2005, title={Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus}, volume={202}, ISSN={0022-1007}, url={http://dx.doi.org/10.1084/jem.20050338}, DOI={10.1084/jem.20050338}, number={2}, journal={The Journal of Experimental Medicine}, publisher={Rockefeller University Press}, author={Christensen, Sean R. and Kashgarian, Michael and Alexopoulou, Lena and Flavell, Richard A. and Akira, Shizuo and Shlomchik, Mark J.}, year={2005}, month=jul, pages={321–331} }